Conference
A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study
Authors
Raskob GE; Van Es N; Verhamme P; Carrier M; Di Nisio M; Garcia DA; Grosso MA; Kakkar AK; Kovacs MJ; Mercuri MF
Volume
130
Publisher
AMER SOC HEMATOLOGY
Publication Date
December 7, 2017
Name of conference
59th Annual Meeting of the American-Society-of-Hematology (ASH)
Conference place
GA, Atlanta
Conference start date
December 9, 2017
Conference end date
December 12, 2017
Conference proceedings
BLOOD
ISSN
0006-4971